Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronate 0.1% vs 0.2% for Post-Cataract Discomfort
NCT03705949Completed
- Sponsor
- Democritus University of Thrace
- Start
- Sep 2017
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of sodium hyaluronate in postoperative pain and dry eye syndrome (DED) (2 arms), sponsored by Democritus University of Thrace. Primary endpoint: Surface Discomfort Index at 6 weeks. Started Sep 2017; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
postoperative paindry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03705949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705949.